Business · 1 sources covering this

AstraZeneca strikes $40 million AI drug discovery deal with Insitro

The multi-year partnership will target severe liver and heart conditions, with insitro eligible for up to $1.46 billion in development and commercial milestone payments

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
AstraZeneca strikes $40 million AI drug discovery deal with Insitro
The multi-year partnership will target severe liver and heart conditions, with insitro eligible for up to $1.46 billion in development and commercial milestone payments
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/1e77bddcce2ae084f7091605689adfeb326c8aa6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="AstraZeneca strikes $40 million AI drug discovery deal with Insitro"></iframe>

AstraZeneca strikes $40 million AI drug discovery deal with Insitro

How 1 sources are covering this

AstraZeneca strikes $40 million AI drug discovery deal with Insitro

More from Business

Nvidia, Apple among donors to Trump's $400 million White House ballroom project: Report

UCO Bank net profit rises 27% to ₹786 crore in July-September quarter

Zelenskyy defies Trump's energy ceasefire call, orders Russia strikes

Why Was Kuldeep Yadav Dropped? Ashwin Questions India’s Call, Says 'Very Surprising’

Reader

Trust & legal

Across the network